Drug Trial Radar · NCT07390552
A Study of PLH-2301 in Subjects With Sarcopenia
Last checked: Nov 19, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
168
Planned (sponsor's estimate)
Start
May 8, 2026
Primary completion
Jun 30, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Pluto Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Symyoo
- First posted
- Feb 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of PLH-2301 in subjects with sarcopenia. Eligible subjects aged 65 years and older will be randomized to receive placebo or one of three dose levels of PLH-2301 once daily for 12 weeks. The primary objective is to assess the effect of PLH-2301 on physical function compared with placebo.
Conditions
- Sarcopenia in Elderly
Interventions
PLH-2301Drug
PLH-2301 administered orally according to assigned dosing regimen.
PlaceboDrug
Matching placebo administered orally according to assigned dosing regimen.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Short Physical Performance Battery (SPPB) total scoreTime frame: Baseline to Week 12
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea · Recruiting
The Catholic University of Korea, St. Vincent's Hospital
Suwon, Gyeonggi-do, South Korea · Recruiting
Korea University Anam Hospital
Seoul, Seoul, South Korea · Recruiting
Seoul St. Mary's Hospital
Seoul, Seoul, South Korea · Recruiting
Korea University Guro Hospital
Seoul, Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.